25-11-2025 14:04 via rocketnews.com

Novo Nordisk’s weight-loss-drug trial provides rare good news in a rocky year

Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in development.
Article Attribution | Read More at Article Source
The post Novo Nordisk’s weight-loss-drug trial provides rare good news in a rocky year appeared first on RocketNews.
Read more »

Analyst news



Dell rides a boom in AI servers to deliver an upbeat forecast
Urban Outfitters says shoppers are holding out for deals, but sees little pushback on its prices
Weekly Economic Calendar for 01.12.2025–07.12.2025
Weekly Economic Calendar for 01.12.2025–07.12.2025
I’m 59. Does it make financial sense to raid my $2.5 million IRA to buy a $400K home?
‘I have no paperwork’: My father gave me my mother’s jewelry before he died. Will I owe taxes if I sell?
Kohl’s enjoys meme-stock-style rally, but this time it’s based on actual good news
Nvidia’s stock drops on Google fears. Are investors missing the point?
A ‘tale of two retirements’ shows only the rich are saving more — while most Americans are putting away much less
Burlington is still a coat factory to many shoppers, and that was a bad thing this year
Home sellers face a tough choice right now: cut their asking price, or roll the dice on a better deal later
Retail sales tapered off before the shutdown. Will they perk up for the holiday shopping season?
Fund manager who ‘pounded the table’ to own Nvidia in 2017 now likes these AI stocks
Wholesale inflation was fairly tame before government shutdown, but PPI unlikely to sway the Fed
Kohl’s stock enjoys meme-like rally as blowout earnings confirm turnaround has taken hold
Desktop versie